Dynorphin, a novel paracrine factor that regulates insulin secretion
强啡肽,一种调节胰岛素分泌的新型旁分泌因子
基本信息
- 批准号:10658268
- 负责人:
- 金额:$ 38.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-17 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:Beta CellBindingCell CommunicationCell physiologyCell secretionCellsCommunicationComplementD CellsDataDiabetes MellitusDiseaseDynorphinsEpidemicExposure toFamilyFeedbackGenesGeneticGlucagonGlucoseGoalsHigh Fat DietHormonalHormone secretionHormonesHumanHyperglycemiaImpairmentIn VitroIncubatedInsulinInsulin ResistanceIslet CellIslets of LangerhansKnowledgeLifeMessenger RNAModelingMusNon-Insulin-Dependent Diabetes MellitusOpioid AntagonistOpioid PeptideOpioid ReceptorOutcomePainParacrine CommunicationPathologicPhenotypePhysiologicalPhysiologyPublic HealthPublishingRegulationResearchRoleSignal TransductionSomatostatinSystemTestingTherapeuticWorkaddictionbiological adaptation to stressblood glucose regulationcell injurydesigndiabetes managementdiabetogenicendogenous opioidsexperimental studygamma-Aminobutyric Acidglucose metabolismimprovedin vivoinnovationinsulin granuleinsulin secretionisletkappa opioid receptorsmouse modelnovelnovel strategiesoverexpressionparacrinepharmacologicprogramsresponsetherapeutic targeturocortin
项目摘要
Dynorphin, a novel paracrine factor that regulates insulin secretion
The inability to maintain glucose homeostasis leads to diabetes, a life-threatening disease of epidemic
proportions. The adaptation of pancreatic islets to insulin resistance is a significant determinant of developing
type 2 diabetes (T2D). Within the pancreatic islet, the crosstalk between different islet cells through paracrine
signals orchestrates a hormonal response that controls glucose levels. Dysregulation of these signals contributes
to impaired glucose homeostasis and diabetes.
The long-term goal of my research program is to understand how paracrine interactions within islet cells
regulate hormone secretion and glucose homeostasis in physiological and pathological conditions. The objective
of this proposal is to assess the β- to δ-cell Dynorphin (Dyn)/Kappa opioid receptor (KOR) negative feedback
loop during physiology and pathological states. The central hypothesis is that insulin secretion is regulated by a
novel β- to δ-cell Dyn/KOR negative feedback loop, and this feedback loop regulates glucose homeostasis and
contributes to hyperglycemia in diabetes. The rationale underlying this proposal is that completion will identify
key targets for improving insulin secretion in conditions of insulin resistance and diabetes. The central hypothesis
will be tested by pursuing two specific aims:
1) Characterize the Dyn secretion in mouse and human β-cells and determine the contribution to islet function
and glucose homeostasis (First component of the feedback loop).
2) Determine the role of δ-cell KOR and examine the potential of the Dyn/KOR axis as a therapeutic target in
diabetes (Second component of the feedback loop).
We will pursue these aims using an innovative combination of newly generated mice models with specific
deletion of KOR in δ-cells and overexpression and deletion of Dyn in β-cells.
The proposed research is significant because it will identify that the endogenous opioid peptide Dyn, is a key
intra-islet paracrine molecule that regulates insulin secretion and glucose homeostasis. It is also significant
because it will reveal how the regulation of KOR impacts islet secretion in diabetogenic conditions. This work will
develop foundational knowledge of how Dyn and its function in islet cells impact glucose metabolism and insulin
resistance. The proximate expected outcome of this work is understanding the mechanism of how the Dyn/KOR
axis participates in the adaptation of β-cells to insulin resistance and β-cell injury.
The results will have an important positive impact immediately. After all, we will uncover the role of the
Dyn/KOR axis in islet function. Resolving the in vivo mechanisms of β- to δ-cell Dyn/KOR negative feedback
loop will have profound implications for glucose homeostasis and serve to develop potential targets for T2D.
强啡肽:一种新的调节胰岛素分泌的旁分泌因子
无法维持葡萄糖稳态会导致糖尿病,这是一种危及生命的流行性疾病
比例。胰岛对胰岛素抵抗的适应性是胰腺癌发生的重要决定因素。
2型糖尿病(T2 D)。在胰岛内,不同胰岛细胞之间通过旁分泌的串扰
信号协调控制葡萄糖水平的激素反应。这些信号的失调有助于
葡萄糖稳态受损和糖尿病。
我的研究项目的长期目标是了解胰岛细胞内的旁分泌相互作用
在生理和病理条件下调节激素分泌和葡萄糖稳态。客观
该建议的一个目的是评估β-至δ-细胞强啡肽(Dyn)/κ阿片受体(KOR)的负反馈
在生理和病理状态下循环。核心假设是胰岛素分泌是由一种
新的β-至δ-细胞Dyn/KOR负反馈回路,该反馈回路调节葡萄糖稳态,
导致糖尿病的高血糖症。这项建议的基本理由是,完成这项工作将确定
在胰岛素抵抗和糖尿病条件下改善胰岛素分泌的关键目标。核心假设
将通过追求两个具体目标进行测试:
1)表征小鼠和人β细胞中的Dyn分泌,并确定对胰岛功能的贡献
和葡萄糖稳态(反馈回路的第一个组成部分)。
2)确定δ细胞KOR的作用,并检查Dyn/KOR轴作为治疗靶点的潜力,
糖尿病(反馈循环的第二个组成部分)。
我们将使用新产生的小鼠模型与特定的
δ-细胞中KOR的缺失和β-细胞中Dyn的过表达和缺失。
这项研究具有重要意义,因为它将确定内源性阿片肽Dyn是一个关键因素,
调节胰岛素分泌和葡萄糖稳态的胰岛内旁分泌分子。有着现实的指导意义
因为它将揭示在糖尿病发生条件下KOR的调节如何影响胰岛分泌。这项工作将
发展Dyn及其在胰岛细胞中的功能如何影响葡萄糖代谢和胰岛素的基础知识
阻力这项工作的最接近的预期成果是了解Dyn/KOR如何
轴参与β细胞对胰岛素抵抗和β细胞损伤的适应。
结果将立即产生重要的积极影响。毕竟,我们将揭示的作用,
Dyn/KOR轴在胰岛功能中的作用解决β-到δ-细胞Dyn/KOR负反馈的体内机制
环将对葡萄糖稳态产生深远的影响,并有助于开发T2 D的潜在靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manuel Blandino-Rosano其他文献
Manuel Blandino-Rosano的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Continuing Grant
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Discovery Projects
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Fellowship
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Research Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Standard Grant
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Standard Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Discovery Projects
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 38.38万 - 项目类别:
Research Grant